Shares of Odyssey Therapeutics Inc., a clinical-stage biopharmaceutical company, are expected to begin trading on the Nasdaq Capital Market on May 8, 2026, under the ticker symbol "ODTX".
The company has priced its initial public offering of 15.50 million shares of its common stock at $18.00 each. The offering, which is scheduled to close on or about May 11, 2026, is expected to rake in gross proceeds of approximately $304 million.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.